ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink, Inc. (OTCBB:GNLK.OB, “the Company,” or “GeneLink”), a leading consumer genomics biotech company, today reported financial results for the fiscal 2009 three-month period ended March 31, 2009.
ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink, Inc. (OTCBB:GNLK.OB, “the Company,” or “GeneLink”), a leading consumer genomics biotech company, today reported financial results for the fiscal 2009 three-month period ended March 31, 2009.
